Hospital giving women a green whistle to help with IUD pain relief, page-40

First 40 Last

Share
Profile

Follow
VascoDaG

455 Posts.

78

10/01/24

08:39

Post #: 71803702
Share

Originally posted by prazzzz: ↑

I am starting to get a bit pissed with management to be honest. For a small/ nimble and supposed to be fast growing company they have 2 announcements to make every twelve months and they are half yearly and annual report. There is hardly any progress in between and even the 6 monthly - it is "in progress" news and nothing substantial.

1. The US trials are now 2 years in since FDA gave them clearance, and guess what ZERO progress towards commercialisation. In fact, Clinical trials will yet not happen this FY. Reasoning? Well, not sure!!!
2. France was the Go-to growth market and they just pulled out of it with couple of statements in half-yearly. So where to from here - won't tell you until the next half yearly.

I won't be surprised if management are starting to sell as the only person that has a decent buy in this company is the chairman. I think everyone else is on a free ride with his money on the line.

What a shithouse - Company valued at $50m net of cash for 40% annual growth. I do not think the business or their technology is the reflection of the share-price - it is lack of meaningful execution.

Expand

Value won’t be unlocked till business is at scale / large volume. Low sales price, high cost base. This is why working out an effective sales strategy is proving more challenging than once thought. Product is great, penetrating the right areas of market is the challenge

MVP Price at posting: 97.5¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply